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This descriptive study examined the prevalence of pharmacological and 
psychopharmacological medication use in a Head Start preschool sample, as well as 
trends in medication use based on gender, ethnicity, and behavioral characteristics. The 
participants for this study included 1,544 parents of children ages 2 to 5 years old 
enrolled in a Head Start program during the 2008-2009 academic year in three diverse 
Michigan counties. Fifteen percent of children in this sample (n =233) were taking 
medication on a regular basis according to parent report. Pharmacological treatments 
accounted for 98.2% (n =306) of the medications in the sample. Sixty-nine percent (n 
=214) of medications reported were asthma related, significantly less than was reported 
in this population of children just two years ago. The importance of educating parents 
about the lack of a research base and potential side effects of common medications given 
to preschool children is discussed. 
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There is a paucity of research concerning the prevalence rate of pharmacological and 
psychopharmacological medication in the preschool population. Pharmacological medications 
are those drugs that are used to relieve the symptoms of physical ailments such as the common 
cold or a headache, whereas psychopharmacological medications (e.g. sedatives, mood 
stabilizers, psychostimulants) are drugs that relieve the symptoms of psychiatric disorders (Elder, 
Evans, & Nizette, 2009). The umbrella term “medication” frequently includes both 
pharmacologic and psychopharmacological medications. A great need exists for understanding 
the scope of medication use given the possible deleterious effects of these medicines when used 
in young children. One recent study found that 6.8% of children in a Head Start sample were 
taking a prescribed medication according to parent report (Brinkman & Carlson, 2008). Another 
study found that almost 10% of children take over-the-counter medication at any given time 
(Vernacchio, Kelley, Kaufman, & Mitchell, 2008). These data indicate that at least one child in 
every preschool classroom may be taking medications which might affect their classroom 
functioning.  
Currently, asthma is the most prevalent chronic childhood illness in the United States 
(Medco Health Solutions, 2004). It is estimated that eighty percent of children who have asthma 
also have allergies, and often children will take multiple medications concurrently to treat these 
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conditions (American Academy of Pediatrics, 2010). In a study done by Brinkman and Carlson 
(2008), 88% of children in a Head Start sample taking medication were taking one or more 
medications to treat asthma. Asthma medication rates vary, and a decrease in medication usage is 
associated with children less than five years of age, Medicaid insurance, Spanish language, 
asthma severity, and access to physicians and nurses (Eggleston et al., 1998; Halterman, Aligne, 
Auinger, McBride, & Szilagyi, 2000). Only 22% to 32% of children considered at-risk who are 
diagnosed with asthma take medication to control their asthma (Diaz et al., 2000; Halterman et. 
al., 2000). The side effects of asthma medications in preschoolers are not well known, especially 
when multiple medications are prescribed. Side effects of Albuterol, a popular quick-relief 
asthma medication, are known to include tremors, hyperactivity, and vomiting (Schuh et al., 
1989).  Most of the asthma literature focuses on the efficacy of treatment, as well as patient 
education, management, and compliance with respect to asthma medication (Amirav, Newhouse, 
Minocchieri, Castro-Rodriguez, & Schuepp, 2010).   
 The use of over-the-counter (OTC) medications within pediatric populations has recently 
received considerable media attention. Currently, the FDA advises parents that cold and cough 
medications are not approved for preschool children (0-5 years of age) due to a lack of data, 
though few OTC drugs have data supporting that they are not safe or efficacious in young 
children (Vernacchio et al., 2008). Approximately 70% of childhood illnesses, such as common 
colds, are treated with over-the-counter medications. (Kogan, Pappas, Yu, & Kotelchuck, 1994). 
The impact of cold and cough medications is widespread, as it is estimated that in any given 
week, 10.1% of American children use a cold and cough medication (Vernacchio et al., 2008). 
 Side effects of decongestants include headaches, nausea, vomiting, loss of appetite, 
hypertension, seizures, and sedation (Clemens et al., 1997; Smith, Henman, Schroeder & Fahey, 
2008). Antihistamines used to treat allergies are considered to be the safest OTC medications, yet 
side effects of antihistamines include headache, dry mouth, nose, and throat, drowsiness, 
dizziness, hallucinations, hyperactivity, and muscle weakness (Clemens et al., 1997; Hoffer, 
2003). Dart and colleagues (2009) reviewed 189 fatalities involving children under twelve years 
old and the presence of medications. Sixty-two percent of fatalities involved a non-prescription 
drug, and over-dosage was linked to 75% of the non-prescription drug deaths.  In the most severe 
cases, OTC cold and cough medications have been associated with neurologic impairments, 
unstable heart rates, and toxic exposure resulting in death (Vernacchio et al., 2008).    
 Although evidence suggests that OTC medication use among the pediatric population has 
reached a plateau, psychotropic medication use within the preschool population is rising - despite 
the fact that little is known about the long-term effects (Coyle, 2000). Antipsychotic medications 
prescribed to preschoolers on Medicare have doubled since 1990 (Fanton & Gleason, 2009) and 
surpass spending for pediatric asthma medications (Medco Health Solutions, 2004). Meta-
analyses of children across the country indicate that stimulant and antidepressant use has 
increased from 0.3% to 1% among children six to fourteen years old (Olfson, Marcus, 
Weissman, & Jensen, 2002), but other reports indicate that psychotropic medications are used 
rarely (less than .03%) within the preschool population (Brinkman & Carlson, 2008). 
The prescription rate for psychotropic medications, while infrequent within preschool 
populations, greatly outpaces the research base to support the practice (American Psychological 
Association Working Group, 2006). Over the past decade, there has been a notable increase in 
the prescription rates of psychotropic medication in the preschool population (Luby, Stalets, & 
Beldon, 2007; Martin & Leslie, 2003; Olfson et al., 2002; Zito, Safer, & dosReis, 2000; Zito et 
al., 2007). Percentages of psychotropic medications prescribed to preschoolers range from 0.16% 
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(Oflson, Crystal, Huang, & Gerhard, 2010) to 2.7% (Zito et al., 2007). Analyses of prescription 
data indicate that primary care physicians are more likely than specialized physicians to 
prescribe psychotropic medications to young children (Rappley, 2006), and there are significant 
differences in prescription rates based on insurance coverage (Zito et al., 2007).   
Little is known about the general long-term effects of psychotropic medications on neural 
development, nor do researchers understand the effects of certain drugs, dosages, or duration of 
exposure (Greenhill, 1998). However, some children require pharmacological interventions to 
reduce morbidity and mortality. Studies using experimental animals to understand the effect of 
psychotropic medications indicate that the medications alter cortical synaptic density and 
dopamine and norephinephrine levels, and cause memory deficits (Coyle, 2000). This is 
problematic, considering that researchers do know that during the first few years of life, the brain 
undergoes the most synaptogenesis and pruning of neural networks and is highly sensitive to 
environmental and chemical factors (Fanton & Gleason, 2009). “Black box” warnings issued by 
the Food and Drug Administration (FDA) on some antidepressants that may be prescribed for 
children, such as clomipramine (Anafril) and fluoxetine (Prozac), warn caregivers and physicians 
of the potential side effects and dangers of the medication (Leslie, Newman, Chesney, & Perrin, 
2005) (Table 1). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
86     SEIF & CARLSON 
 
 
Table 1 
Psychopharmacological Medications Approved by the FDA  
and Specific Treatment Indications by Age 
Trade Name Generic Name Approved Age 
Stimulant Medications for ADHD 
  
  
Adderall Amphetamine  3 and older 
Adderall XR Amphetamine (extended release) 6 and older 
Concerta Methylphenidate (long acting) 6 and older 
Dexedrine Dextropmphetamine 3 and older 
Dextrostat Dextropmphetamine 3 and older 
Focalin Dexmethylphenidate 6 and older 
Metadate ER Methylphenidate (extended release) 6 and older 
Methylin Methylphenidate (liquid/chewable available) 6 and older 
Ritalin Methylphenidate 6 and older 
Nonstimulant for ADHD 
  
  
Strattera Atomoxetine 6 and older 
Antidepressant and antianxiety medications 
  
  
Anafril Clomipramine 10 and older (for OCD) 
Prozac Fluoxetine 8 and older (for depression/OCD) 
Luvox (SSRI) Fluvoxamine 8 and older (for OCD) 
Sinequan Doxepin 12 and older 
Tofranil Imipramine 6 and older (for bedwetting) 
Zoloft (SSRI) Setraline 6 and older (for OCD) 
Risperdal Risperidone 13 and older (for Schizophrenia) 
Antipsychotic Medications 
  
  
Haldrol Haloperidol 3 and older 
Mellaril Thioridazine 2 and older 
Orap Pimozide 12 and older (Tourette's Syndrome) 
Thorazine Chloropromazine 1 and older (Severe Behavior 
Problems) 
Mood Stabilizing Medications 
  
  
Cibalith-S Lithium citrate 12 and older 
Depakote Valproic acid 2 and older (for seizures) 
Eskalith Lithium carbonate 12 and older 
Lithobid Lithium carbonate 12 and older 
Tegretol Carbamazeprine 12 and older (for seizures) 
Alpha-agonist     
Catapres Clonidine Not approved for children (Tourette's 
Syndrome/ADHD) 
Note. Adapted from Carlson, J. (2008).  Best practices in assessing the effects of psychotropic medications on 
student performance. In Thomas, A. & Grimes, J. (Eds.), Best Practices in School Psychology V (p.1381). Bethesda, 
MD: NASP. Permission was granted from the author to use reproduce this table in this publication.  
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METHOD 
 
Participants 
 
The sample for this study included 1,544 parents or caregivers of children ages two to five years 
old enrolled in a Head Start program during the 2008-2009 academic year in three diverse 
Michigan counties. The ethnicity of the entire Head Start sample was 28.5% (n = 440) African 
American, 40% (n = 624) Caucasian, 9.5% Hispanic (n = 147), 19% Multiracial  
(n = 293), and 3% (n = 40) other. Half of the preschoolers were male (50.8%; n = 784) and half 
were female (49.2%; n = 760). Seventy-five percent were from single parent homes and 25% 
were from two parent homes. Ninety-six percent of students qualified for Head Start based on 
family income. All children in the sample had either private or county-provided insurance 
coverage. All participants in the data set were used in the study.  
 Fifteen percent (n = 233) were reported by parents to be taking medication on a regular 
basis (see Table 3). Since data regarding the specific type of medication prevalence data was 
missing for 3% (n = 7) of children, specific medication prevalence data were analyzed based on a 
sample of 226. The ethnicity of the Head Start children taking medication was 46% (n = 108) 
African American, 36% (n = 85) Caucasian, 12% (n = 27) Hispanic, 3% (n = 8) Multiracial, and 
2% (n = 5) Other. Fifty-eight percent (n = 136) of the children taking medication were males, 
and 42% (n = 97) were females (See Table 2). The mean age of students taking medication was 
3.94 years. 
 
 
Procedure   
 
Non-identifying data for this study were gathered from existing Head Start initial enrollment 
packet records in an attempt to help the program better understand and meet the needs of those 
children who were taking medications. The methods of this study were similar to the methods 
used in a study by Brinkman and Carlson (2008). Brinkman and Carlson (2008) used self-report 
data from 89 Head Start Enrollment records to determine the prevalence of medication use in a 
three county Head Start population in a Midwestern state.  This study examined an additional 
question on the Head Start enrollment sheet pertaining to behavioral characteristics to explore 
the relationship between medication use and social-emotional behavior given prior links 
discussed within the literature (eg., McNelis et al., 2000; Michael 2002). Approval for review of 
this existing data set was obtained by the author’s Institutional Review Board and the local Head 
Start Administrative team.   
 
 
Measurements   
 
Medication use was determined by parental responses to a series of questions about medication 
use that were part of each child’s initial enrollment packet: “Is your child taking any 
medication(s) on a regular basis (including over-the-counter, creams, lotions, herbal 
remedies, and seasonal)?  “If yes, list all medication(s) and what it is taken for.”  The 
prompts used by Brinkman and Carlson (2008) were less detailed: “Is your child taking any 
medications on a regular basis? If yes list the medication and what it is taken for.” The researcher 
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defined asthma and allergy medications based on the type of specific medication reportedly used 
(Physicians’ Desk Reference, 2006; Robertson & Shilkofski, 2005). The short-acting beta-
antagonists (Albuterol, Xopenex) comprised the quick-relief medications used by the 
preschoolers in this study. Long-term control asthma medications included inhaled 
corticosteroids (Pulmicort, Flovent), leukotriene modifier (Singulair), anti-inflammatory agent 
(Cromolyn), and combined long-acting beta antagonist and inhaled corticosteroid (Advair).  
Other medications were classified as gastrointestinal, seizure control, and other. Psychotropic 
medications were defined as those commonly used to treat childhood psychiatric disorders 
(Jensen et al., 1999). 
Parental responses to the question (also part of the initial enrollment packet), “Is there 
anything you want us to know about your child’s personality or temperament which will 
help us to support his or her adjustment to Head Start?” were coded according to the 
following categories:  internalizing behaviors (eg., “Separation Anxiety,” “Shy,”), externalizing 
behaviors (eg., “Yelling,” “Biting,” “Bad Temper”), adaptive skills (eg., “Considerate,” “Wants 
to interact with others,” “Very mature”), and nonadaptive skills (eg., “Trouble sharing,” 
“Frustrated Easily,” “Doesn’t Listen”). Six responses were not coded since they reflected 
parenting behavior instead of child personality (e.g., “Spoiled”). The researcher chose to 
categorize qualitative personality data based on internalizing behaviors, externalizing behaviors, 
adaptive, and non-adaptive skills based on the composite indexes of the Behavior Assessment 
System for Children, Second Edition (BASC-2) parent rating scales.  The BASC-2 composites 
have high internal consistency and test-retest reliability, and are considered to be a reliable 
assessment of personality, behavioral, and emotional dimensions of children 2 to 21 years of age 
(Reynolds & Kamphaus, 2004). In addition to the researcher, two undergraduate students with 
experience in coding and data processing coded the responses. The internal-consistency 
reliability value for data coding was .9. Alpha levels greater than .7 are considered “acceptable,” 
greater than .8 are considered “good,” and greater than .9 are considered “excellent” (George & 
Mallery, 2003). 
 
 
Data analysis 
 
The Statistical Package for the Social Sciences (SPSS) was used to conduct the analyses. The 
first research question was: What are the prevalence rates and types of medications reported to 
be taken by preschool children enrolled in Head Start? In order to address this question, 
descriptive statistics were calculated to determine the types of medication children were reported 
to be taking, and the prevalence of each medication in the sample.   
The second research question was: How do types of medications vary by ethnicity and 
gender in a Michigan Head Start preschool population? To address this question, Chi-Square 
analyses were conducted to examine the proportion of children taking medication based on 
demographic factors such as gender and ethnicity. After medications were divided into 
categories (long-term-control and quick-relief asthma medications, OTC medications, and 
psychotropic medications), Fischer’s Exact Tests were conducted to test for significant 
differences between type of medication use, as well as gender and ethnicity.   
 The third research question was: What are common associated behavioral characteristics 
of those children who are reported to be taking medication? A Pearson’s correlational analysis 
was conducted to test for relationships between each type of asthma medication and each of the 
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four personality variables: externalizing behaviors, internalizing behaviors, adaptive skills, and 
nonadaptive skills. Normality assumptions of the Pearson’s correlation coefficient were fulfilled. 
According to the literature, correlations less than .30 are considered “low,” correlations between 
.30 and .70 are considered “medium,” and correlations between .70 and .90 are considered 
“high” (Spencer, 1995). 
 
 
RESULTS 
 
Two hundred and thirty three children were reported to be taking medication on a regular basis, 
representing 15% of the Head Start sample. The average number of medications reported per 
child was 1.67 (SD = 1.3). Over half of the children (56%) taking medications were taking one 
type of medication, and 27% of the children taking medications were taking two medications. 
The most common combination of medication was a quick-relief and a long-term asthma 
medication. Approximately one-third of students (34%) taking medications were taking a 
combination of long and short-term asthma medications.  
 
 
TABLE 2 
Demographic Characteristics of Children Taking Medications  
as a Percentage of the Sample 
  Overall Sample Medication Sample 
Characteristic (n = 1544) (n = 233) 
Race   
  African American 28.5     (440) 46.0**   (108) 
  Caucasian 40.4     (624) 36.0       (85) 
  Hispanic   9.5     (147) 12.0       (27) 
  Multiracial 19.0     (293)        3.0**     (8) 
  Other   2.6       (40)   2.0         (5)    
   
Gender   
  Male 50.8     (784) 58.0*     (136) 
  Female 49.2     (760) 42.0         (97) 
Note. P values are based on Chi Square Tests of Independence.  
*p < .05, ** p < .001 
 
 
 Chi-square tests of independence were performed to examine the relationship between 
ethnicity and medication usage, as well as gender and medication usage (Table 2). The 
relationship between ethnicity and medication usage was significant, 2 (4, n =1544) = 68.44, p 
< 0.01. Examination of the standardized residuals indicated African American children were 
more likely to be taking medication than any other ethnic group, and Multiracial children were 
less likely to be taking medication than any other ethnic group. A second chi-square test of 
independence was performed to examine the relationship between gender and medication usage. 
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The relationship between these variables was significant, 2 (1, n =1544) = 5.95, p < 0.05 (Table 
2). Males were more likely than females to be taking medication.  
 As shown in Table 3, psychopharmacological treatments accounted for 1.4% (n = 4) of 
the medications in the sample, while pharmacological treatments accounted for 98.6% of the 
medications in the sample. Asthma medications comprised 68.5% of all medications, and allergy 
medications comprised 20.5% of all medications. Seventy-eight percent of all medications were 
prescription medications, and 22% were over-the-counter medications. Of the children taking 
asthma medications, 51.5% (n =114) of asthma medications were quick-relief asthma 
medications, while 48.5% (n =100) were long-term control asthma medications. Loratadine 
(Claritin) was the most widely used allergy medication, followed by cetirizine (Zyrtec) and 
diphenhydramine (Benadryl). Twenty-six of the children who were taking allergy medications 
were also taking asthma medications, indicating that 16% of children taking asthma medications 
were also taking an allergy medication.  
 Results of Fischer’s Exact tests indicated gender was a factor in differences in medication 
use (See Table 4). Males were more likely to be taking any type of medication with a prevalence 
of 17.3% (136/784), compared to 12.8% (97/760) of females (p = 0.01). However, males were 
not any more likely to be taking an asthma medication (p = 0.15) or psychotropic medication 
than females (p = 0.12). There were also significant differences in asthma medication usage 
based on ethnicity. African American students were more likely to be taking any type of 
medication with a prevalence of 25% (108/440), compared to 14% (85/624) of Caucasian 
students (p <0.001). This was predominantly due to the fact that African American students were 
more likely to take asthma medication with a prevalence of 23.0% (101/440), compared to 
10.1% (63/624) of Caucasian students (p <0.001). Hispanic students too were more likely to take 
asthma medication than Caucasian students with a prevalence of 17.7% (26/147) compared to 
10.1% (63/624) of Caucasian students (p = 0.01). African American students were not any more 
likely to take asthma medications than Hispanic students with a prevalence of 23% (101/440) 
compared to 17.7% (26/147) of Hispanic students (p = 0.20). 
 Significant differences based on ethnicity also existed in the types of asthma medication 
students used. African American students were more likely to take a quick-relief asthma 
medication with a prevalence of 15.7% (69/440), compared to 5.0% (31/624) of Caucasian 
students (p <0.001). Caucasian students were more likely to take a long-term-control asthma 
medication with a prevalence of 5.4% (34/624), compared to 9.0% (40/440) of African American 
students (p = 0.03).  
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TABLE 3 
Prevalence of Medications Taken by Children in the Sample (n =312) 
Medication Percentage n 
Asthma 68.5 214 
  Quick Relief 36.5 114 
    Albuterol 33.3 104 
    Pro Air 0.3 1 
    Xopenex 2.9 9 
   
  Long-Term Control     32.1 100 
    Pulmicort 14.1 44 
    Singulair 14.7 46 
    Flovent 3.2 10 
   
Allergy 20.5 64 
  Prescription 0.9 3 
    Allegra 0.3 1 
    Nasonex 0.3 1 
    Flonase 0.3 1 
   
  OTC 19.6 61 
    Claritin 11.5 36 
    Zyrtec 4.8 15 
    Benadryl 2.9 9 
    Saline Spray 0.3 1 
   
General Prescription 5.8 18 
    Prevacid 3.8 12 
    Antibiotics 0.6 2 
    Tylenol with Codeine 0.6 2 
    Exjade 0.3 1 
    Reglan 0.3 1 
   
General OTC Medication 2.2 7 
    Cold/Cough 0.6 2 
    Stool Softener 0.6 2 
    Vitamins/Minerals 0.9 3 
   
Psychotropic 1.3 4 
   
Skin 1.6 5 
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TABLE 4 
P values of Demographic Differences in Medication Usage 
  Medication   Asthma Medication 
  Any Psychotropic   Any Quick Relief Long-term  
Males/Females         0.013* 0.1250  0.1520 0.3100 0.3790 
African American/Caucasian    < 0.0001*** 0.5730     <0.0001***    <0.0001*** 0.027* 
African American/Hispanic 0.1413   0.2040 0.1760 0.3040 
Caucasian/Hispanic 0.1526     0.014* 0.0120 0.6930 
Note. P values are based on Fischer’s Exact Test.  
*p < .05, *** p < .001 
 
MEDICATION PREVALENCE IN A HEAD START SAMPLE     93 
 
Results of Pearson correlational analyses indicated no relationship between asthma 
medications and behavioral characteristics. Children who took Albuterol, Pulmicort, or Singulair 
were not any more or less likely to exhibit internalizing, externalizing, adaptive, or maladaptive 
behaviors than children who were not taking those types of medications. As shown in Table 5, 
28% of the students (n = 35) displayed internalizing behaviors, such as keeping to themselves or 
withdrawing from others. Twenty-seven percent (n = 32) of the students taking allergy and 
asthma medications displayed externalizing behaviors, such as yelling or biting. The same 
number of students (n = 32) displayed maladaptive behaviors, such as having difficulty 
transitioning or becoming easily frustrated. A smaller percentage (19%; n = 24) of students 
exhibited adaptive behaviors, such as helping others or getting along well with others.  Similar 
patterns were present among children taking allergy medications in addition to other types of 
medications (n = 13). Students were equally as likely to exhibit externalizing (n = 5) or 
internalizing behaviors (n = 5). Fewer children were reported to exhibit externalizing 
characteristics (n = 2) or internalizing characteristics (n = 1). 
 
 
TABLE 5 
Behavioral Characteristics as a Percentage of the Sample 
  Allergies/Asthma 
Allergies/Asthma plus other 
medications 
Characteristic (n=124) (n=233) 
Externalizing 27     (32) 38     (5) 
Internalizing 28     (35) 38     (5) 
Maladaptive 27     (32)   8     (1) 
Adaptive 19     (24) 16     (2) 
 
 
DISCUSSION 
 
The purpose of this descriptive study was to reexamine the prevalence of medications in a Head 
Start preschool sample given previous disparities reported in the literature, analyze trends in 
medication use based on gender and ethnicity, and explore common behavioral concerns in 
children taking medication. Study results indicate a substantial increase in prevalence of 
medication use in our Head Start sample. In 2006, 6.8% (n = 95) of children were taking a 
pharmacological or psychopharmacological medication (Brinkman & Carlson, 2008). Two years 
later, 11% (n = 170) of children representing a similar sample were taking a pharmacological or 
psychopharmacological medication. When asked about all medications, 15% of parents reported 
their child was taking a medication. Although the overall medication prevalence rate increased, 
the average number of medications per child decreased from 2.3 in 2006 (Brinkman & Carlson, 
2008) to 1.67 in 2008, indicating less use of polypharmacy practices within this population. 
The apparent increase in overall medication use within our sample may partly be 
attributed to the change in the prompt in the 2008 Head Start enrollment packet. The 2008 
prompt gave examples of different types of medications caregivers might list, such as OTC 
medications or seasonal medications. The 2006 prompt was more limited and did not provide 
caregivers with examples of medications they could include. As a result, caregivers may not have 
94    SEIF & CARLSON 
 
 
indicated any OTC medications their children were taking when this study was initially 
completed in 2006. This is important to note, since the increase in medication use of the 2008 
sample was primarily the result of OTC allergy medications, specifically loratadine (Claritin) 
and cetirizine (Zyrtec). Cetirizine (Zyrtec) was not available as an OTC medication until 2007 
(Bastianelli, 2008).  
 The majority of prescription medications in this study were used to treat asthma. This is 
consistent with research that indicates preschoolers have the highest asthma rate in the United 
States (Akinbami, Moorman, Garbe, & Sondik, 2009). Results of this study indicated that 18.6% 
(n = 82) of African American children and 7.9% (n = 49) of Caucasian children were taking 
medications to treat asthma. The discrepancy in this sample is larger than what is usually 
reported in the literature. In the United States, approximately 8.5% of all children have asthma, 
with prevalence varying according to race; approximately 12.5% of African American children 
have asthma, whereas only 7.7% of Caucasian children have asthma (Peters & Fritz, 2010).   
 The percentage of psychotropic medications in this sample was surprisingly low, as less 
than one percent of children (n = 4) were reported to be taking psychotropic medications. This is 
only slightly less than the 0.3% reported by Brinkman & Carlson (2008), but much less than 
other studies have reported. For example, Zito and colleagues (2007) reported that 2.3% of 
American preschool children were taking a psychotropic medication. A large body of evidence 
indicates that males are more likely to take psychotropic medications than females (Olfson et al., 
2010; Zito et al., 2007). This study further supports those findings, since all four psychotropic 
medications (i.e. Methylphenidate (Ritalin), Risperidone (Risperidol)) were prescribed to males.  
 In addition, the findings of this study underscore the importance of teaching and caring 
for preschool children - particularly males - with warmth to promote prosocial behaviors. Lack 
of maternal warmth has been associated with increased rates of hyperactivity in boys (Keown, 
2011).  In a recent study, maternal warmth and responsiveness toward boys during the preschool 
years was positively associated with social skill development (Morgan, Shaw, & Forbes, 2014). 
Given the greater vulnerability of boys to hyperactivity and externalizing behaviors that may 
result in medication treatment, the importance of warmth and nurturing toward male students in 
the preschool classroom is essential knowledge for Head Start teachers and staff members. 
 Reported behavioral characteristics indicate that of the children taking allergies and 
asthma medications, approximately the same number of children exhibit externalizing 
characteristics (27%; n = 32) as internalizing characteristics (28%; n = 35) and maladaptive 
characteristics (27%; n = 32). However, this may be due to the belief that externalizing behaviors 
are easier for caregivers to track and recall, when compared to internalizing behaviors (Rockhill 
et al., 2007). The association between mental health issues and childhood asthma is particularly 
important for caregivers and education professionals to understand, since current research 
indicates that the mental health of caregivers of children with asthma may be more important 
than the mental health of children with asthma (Feldman et al., 2011). Caregivers of children 
with asthma may not be aware of the link between their mental health status and the child’s 
response to his asthma.  
 
 
IMPLICATIONS  
 
Prevalence rates of medication use in preschoolers have implications of the education and 
training of early childhood personnel. Providing educational and health services to at-risk 
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children and families are core values of Head Start programs (U.S. Department of Health and 
Human Services, 2010). Knowledge of the effects and side effects of medications for common 
preschool illnesses is important not only for parents of children, but also for those who care for 
them outside of the home setting. In this sample, 43% of the students reported to be taking 
medications were taking a combination of medications with unknown interaction effects. The 
high number of male children and African American children taking medication in this study 
compared to their peers is consistent with the current literature indicating the higher rate of 
asthma in both groups (Diaz et al., 2000; Halterman et al., 2000; Peters & Fritz, 2010).  
Head Start staff members and families need to be equipped with knowledge about 
medication trends based on gender and ethnicity, research behind over-the-counter medications 
and prescription medications used to treat asthma and other common preschool illnesses, and the 
role of children’s and caregivers’ mental health in relation to chronic illness. For example, 
children with asthma have been reported to have frequent sleep interruptions and experience 
fatigue. Behavior problems and poor academic performance sometimes associated with 
medication use need to be considered in light of sleep difficulties, mental health challenges, and 
physical challenges.  
 Although it is common for some physicians to instruct parents to administer OTC 
medication to their children to manage medical conditions, it is important for physicians to 
explain the contraindications of OTC drugs to parents in order for parents to make more 
empowered decisions pertaining to their children’s health. Some physicians rarely inquire about 
the use of OTC medications, and many caregivers do not perceive OTC medications as 
medications (Gunn et al., 2001). Young children are often given improper dosages of over-the-
counter medications by caregivers who have inadequate numeracy skills to determine the correct 
dosage, or are incorrectly swayed by labels and graphics (Lokker et al., 2009). For example, an 
OTC medication featuring an image of an infant on the front cover may not be appropriate for an 
infant, but a child over two years of age. Although combinations of medications are often 
necessary to treat asthma-related conditions, many of the medications used to treat this sample of 
preschoolers have limited safety and efficacy data when used in preschool populations. It is 
important for all caregivers and staff members to know that current data do not indicate cough 
and cold medications are effective in reducing the symptoms of the common cold and cough in 
children (Carr, 2006; Vernacchio et al., 2008). However, this does not diminish the importance 
of treating children’s medical ailments to reduce pain and suffering. 
 Programs and materials about asthma medication and asthma management are usually 
designed for older students and require a high level of resources to access, even though 
preschoolers have the highest asthma rate in the United States (Michael, 2002). More data are 
needed on both pharmacologic and non-pharmacologic interventions for preschool-age children. 
Educating Head Start professionals and caregivers of preschool children about the risk factors 
and protective factors of asthma may encourage caregivers to seek treatment for their children at 
an earlier age. High levels of asthma care, attention, and asthma management strategies are 
protective factors for children with asthma (Berz, Murdock, & Mitchell, 2005). From a 
pragmatic standpoint, families with children attending Head Start need access to educational 
programming concerning children’s health issues that is affordable, efficient, and amenable to 
transportation difficulties that many families in this population face.  
 It is important to encourage caregivers to seek consistent medical care for their children 
to manage their children’s asthma symptoms. In addition, it is important to provide Head Start 
families with information about how to access appropriate health care resources. Children who 
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are living in poverty and who are African American or Latino account for the highest proportion 
of hospitalizations and emergency room use (Lin et al., 1999), and are less likely to receive high 
quality preventative asthma care prior to receiving treatment in a hospital (Finkelstein et al., 
1995). Furthermore, in addition to a lack of preventative medical care, students from low SES 
backgrounds are much more likely to supervise their own medication than their more affluent 
counterparts (Eggleston et al., 1998). Collaboration between health care providers, students, and 
families is important not only to educate staff and families about managing medical conditions, 
but also to empower staff and families with non-pharmacological interventions that could be 
used to enhance treatment options. Although the prevention and reduction of asthma-related 
symptoms is important, some children will always be dependent upon medication. Supporting 
families in dealing with chronic childhood illness and increasing collaboration across health care 
staff, educational staff, and families is an essential component of progressive interventions. 
Asthma care plans, in conjunction with parent education and support services, are helpful in 
optimizing treatment compliance.  
  School psychologists and other professionals in early childhood care settings are well 
trained to monitor the effects of medical interventions and school-based care plans on preschool 
students’ social/emotional well-being and academic performance. They also ensure that families 
are aware of resources to help them manage their child’s condition. Tailoring programs and 
education materials to specific populations may increase the effectiveness of the programming 
and create better long-term outcomes for the children they serve.  
 
 
Limitations 
 
A limitation of this study was the use of parent reported data. In order to maintain privacy or 
avoid social stigma, caregivers may have chosen not to list certain medications – particularly 
psychotropic medications. In addition, based on the wording of the survey prompt, it is difficult 
to determine if caregivers listed medications that their children take on a daily basis, as well as 
medications their children take on a more infrequent basis.  The differences between the 2006 
and 2008 survey prompts make it difficult to compare the medication prevalence of the 2006 
Head Start sample to the 2008 Head Start Sample. In the 2008 prompt, caregivers were 
specifically asked to list OTC medications in addition to other types of medications, which they 
were not asked to list in the 2006 prompt.  
In addition, the small sample sizes used to describe behavioral problems and medication 
use limits the validity of the data, and there was no comparison to children who were not on 
medication. The purpose of this descriptive study was not to imply causation related to asthma 
medication and behavioral challenges, but rather explore if an association exists. However, this is 
difficult to do in light of the other variables that may be affecting this association. Finally, the 
data collection method of this study prohibited the possibility of linking medications to specific 
medical diagnoses, and the results of this study are limited in their generalizability to other 
preschool populations. 
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